Literature DB >> 15374584

Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients.

Monica E Calkins1, Clayton E Curtis, William G Iacono, William M Grove.   

Abstract

Schizophrenia patients and their relatives have been found to exhibit increased reflexive errors on the antisaccade task, suggesting the deficit reflects genetic susceptibility for schizophrenia. To evaluate the degree to which antisaccade error is elevated in schizophrenia relatives, we carried out a meta-analysis of the existing literature and a primary study examining whether the magnitude of reported differences between relative and nonpsychiatric comparison groups could be due to differences in participant inclusion criteria. Meta-analysis yielded a moderate to large effect size across studies comparing relatives and controls (Cohen's d=0.61; Glass' d(g)=0.87). Antisaccade performance in medically and psychiatrically healthy relatives (n=45), who were selected from a larger sample of relatives based on criteria applied to healthy controls, was significantly more impaired than in healthy control participants (d=0.81, d(g)=0.93). Moreover, excluded (n=71) and included relatives did not differ (d=0.14, d(g)=0.13). The results indicate that the antisaccade deficit is a robust phenomenon in unaffected schizophrenia relatives that is not due to differences in inclusion criteria between relatives and controls, and thus are consistent with a growing literature indicating that the antisaccade deficit will be a valuable endophenotype of schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15374584     DOI: 10.1016/j.schres.2003.12.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  32 in total

1.  Executive control in chronic schizophrenia: A perspective from manual stimulus-response compatibility task performance.

Authors:  Simone D Behrwind; Manuel Dafotakis; Sarah Halfter; Kerstin Hobusch; Mark Berthold-Losleben; Edna C Cieslik; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

2.  Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study.

Authors:  Allen D Radant; Dorcas J Dobie; Monica E Calkins; Ann Olincy; David L Braff; Kristin S Cadenhead; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Gregory A Light; Sean P Meichle; Steve P Millard; Jim Mintz; Keith H Nuechterlein; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Ming T Tsuang; Bruce I Turetsky; Debby W Tsuang
Journal:  Psychophysiology       Date:  2010-04-05       Impact factor: 4.016

Review 3.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

Authors:  Beth E Snitz; Angus W Macdonald; Cameron S Carter
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

4.  Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients.

Authors:  Isabelle Amado; Steffen Landgraf; Marie-Chantal Bourdel; Sabinien Leonardi; Marie-Odile Krebs
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

Review 5.  CNTRICS final task selection: working memory.

Authors:  Deanna M Barch; Marc G Berman; Randy Engle; Jessica Hurdelbrink Jones; John Jonides; Angus Macdonald; Derek Evan Nee; Thomas S Redick; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

6.  Does performance on the standard antisaccade task meet the co-familiality criterion for an endophenotype?

Authors:  Deborah L Levy; Elizabeth A Bowman; Larry Abel; Olga Krastoshevsky; Verena Krause; Nancy R Mendell
Journal:  Brain Cogn       Date:  2008-10-07       Impact factor: 2.310

Review 7.  Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives.

Authors:  Angus W MacDonald; Heidi W Thermenos; Deanna M Barch; Larry J Seidman
Journal:  Schizophr Bull       Date:  2008-06-12       Impact factor: 9.306

Review 8.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

9.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

10.  Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression.

Authors:  Margret S H Harris; James L Reilly; Michael E Thase; Matcheri S Keshavan; John A Sweeney
Journal:  Psychiatry Res       Date:  2009-11-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.